PubMed

Preclinical evaluation of the antineoplastic action of 5-aza-2'-deoxycytidine and different histone deacetylase inhibitors on human Ewing's sarcoma cells.

Hurtubise A, Bernstein ML, Momparler RL.

Cancer Cell Int. 2008 Nov 17;8:16.PMID: 19014694 [PubMed]Related articlesFree article

Effect of histone deacetylase inhibitor LAQ824 on antineoplastic action of 5-Aza-2'-deoxycytidine (decitabine) on human breast carcinoma cells.

Hurtubise A, Momparler RL.

Cancer Chemother Pharmacol. 2006 Nov;58(5):618-25. Epub 2006 Jun 17.PMID: 16783580 [PubMed - indexed for MEDLINE]Related articles

Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2'-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells.

Shaker S, Bernstein M, Momparler LF, Momparler RL.

Leuk Res. 2003 May;27(5):437-44.PMID: 12620295 [PubMed - indexed for MEDLINE]Related articles

Interaction of 5-aza-2'-deoxycytidine and depsipeptide on antineoplastic activity and activation of 14-3-3sigma, E-cadherin and tissue inhibitor of metalloproteinase 3 expression in human breast carcinoma cells.

Gagnon J, Shaker S, Primeau M, Hurtubise A, Momparler RL.

Anticancer Drugs. 2003 Mar;14(3):193-202.PMID: 12634613 [PubMed - indexed for MEDLINE]Related articles

Synergistic antineoplastic action of DNA methylation inhibitor 5-AZA-2'-deoxycytidine and histone deacetylase inhibitor depsipeptide on human breast carcinoma cells.

Primeau M, Gagnon J, Momparler RL.

Int J Cancer. 2003 Jan 10;103(2):177-84.PMID: 12455031 [PubMed - indexed for MEDLINE]Related articles

Antineoplastic action of 5-aza-2'-deoxycytidine and phenylbutyrate on human lung carcinoma cells.

Boivin AJ, Momparler LF, Hurtubise A, Momparler RL.

Anticancer Drugs. 2002 Sep;13(8):869-74.PMID: 12394273 [PubMed - indexed for MEDLINE]Related articles

Enhancement of antineoplastic action of 5-aza-2'-deoxycytidine by phenylbutyrate on L1210 leukemic cells.

Lemaire M, Momparler LF, Farinha NJ, Bernstein M, Momparler RL.

Leuk Lymphoma. 2004 Jan;45(1):147-54.PMID: 15061212 [PubMed - indexed for MEDLINE]Related articles

Antineoplastic action of 5-aza-2'-deoxycytidine (Dacogen) and depsipeptide on Raji lymphoma cells.

Shaker S, Bernstein M, Momparler RL.

Oncol Rep. 2004 Jun;11(6):1253-6.PMID: 15138563 [PubMed - indexed for MEDLINE]Related articles

Cancer epigenetics.

Momparler RL.

Oncogene. 2003 Sep 29;22(42):6479-83. Review.PMID: 14528271 [PubMed - indexed for MEDLINE]Related articles

Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer.

Lemaire M, Chabot GG, Raynal NJ, Momparler LF, Hurtubise A, Bernstein ML, Momparler RL.

BMC Cancer. 2008 May 2;8:128.PMID: 18454857 [PubMed - indexed for MEDLINE]Related articlesFree article

Pharmacology of 5-Aza-2'-deoxycytidine (decitabine).

Momparler RL.

Semin Hematol. 2005 Jul;42(3 Suppl 2):S9-16. Review.PMID: 16015507 [PubMed - indexed for MEDLINE]Related articles

Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.

Meng CF, Zhu XJ, Peng G, Dai DQ.

Oncol Rep. 2009 Nov;22(5):1221-7.PMID: 19787243 [PubMed - indexed for MEDLINE]Related articles

HDAC inhibitors act with 5-aza-2'-deoxycytidine to inhibit cell proliferation by suppressing removal of incorporated abases in lung cancer cells.

Chai G, Li L, Zhou W, Wu L, Zhao Y, Wang D, Lu S, Yu Y, Wang H, McNutt MA, Hu YG, Chen Y, Yang Y, Wu X, Otterson GA, Zhu WG.

PLoS One. 2008 Jun 18;3(6):e2445.PMID: 18560576 [PubMed - indexed for MEDLINE]Related articlesFree article

Evaluation of antineoplastic action of 5-aza-2'-deoxycytidine (Dacogen) and docetaxel (Taxotere) on human breast, lung and prostate carcinoma cell lines.

Hurtubise A, Momparler RL.

Anticancer Drugs. 2004 Feb;15(2):161-7.PMID: 15075673 [PubMed - indexed for MEDLINE]Related articles

[5-aza-2'-deoxycytidine induces changes of histone H3-lysine 9 methylation in bladder tumor cells]

Yang N, Li Z.

Zhonghua Yi Xue Za Zhi. 2008 Aug 19;88(32):2295-8. Chinese. PMID: 19087683 [PubMed - indexed for MEDLINE]Related articles

BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer.

Majid S, Dar AA, Ahmad AE, Hirata H, Kawakami K, Shahryari V, Saini S, Tanaka Y, Dahiya AV, Khatri G, Dahiya R.

Carcinogenesis. 2009 Apr;30(4):662-70. Epub 2009 Feb 12.PMID: 19221000 [PubMed - indexed for MEDLINE]Related articles

Activation of expression of p15, p73 and E-cadherin in leukemic cells by different concentrations of 5-aza-2'-deoxycytidine (Decitabine).

Farinha NJ, Shaker S, Lemaire M, Momparler L, Bernstein M, Momparler RL.

Anticancer Res. 2004 Jan-Feb;24(1):75-8.PMID: 15015578 [PubMed - indexed for MEDLINE]Related articles

Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2'-deoxycytidine.

Lemaire M, Momparler LF, Raynal NJ, Bernstein ML, Momparler RL.

Cancer Chemother Pharmacol. 2009 Feb;63(3):411-6. Epub 2008 Apr 9.PMID: 18398609 [PubMed - indexed for MEDLINE]Related articles

A systematic assessment of radiation dose enhancement by 5-Aza-2'-deoxycytidine and histone deacetylase inhibitors in head-and-neck squamous cell carcinoma.

De Schutter H, Kimpe M, Isebaert S, Nuyts S.

Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):904-12.PMID: 19215824 [PubMed - indexed for MEDLINE]Related articles

Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis.

Chung YL, Lee MY, Pui NN.

Carcinogenesis. 2009 Aug;30(8):1387-97. Epub 2009 Apr 7.PMID: 19351790 [PubMed - indexed for MEDLINE]Related articles